Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties

Multiple Sclerosis: Risk Factors and their Interactions

(2012) Giulio Disanto et al.   CNS & Neurological Disorders-Drug Targets

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Bone health and multiple sclerosis

(2012) Ruth Dobson et al.   Multiple Sclerosis Journal

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Vitamin D and disease activity in multiple sclerosis before and during interferon-  treatment

(2012) K. I. Loken-Amsrud et al.   NEUROLOGY

Interferon-  and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

(2012) N. Stewart et al.   NEUROLOGY

Serum IL-17F does not predict poor response to IM IFN -1a in relapsing-remitting MS

(2012) S. E. Bushnell et al.   NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

(2011) Michael F. Holick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A

(2011) S. Joshi et al.   MOLECULAR AND CELLULAR BIOLOGY

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

(2011) M. S. Stein et al.   NEUROLOGY

Serum 25(OH)D concentrations in sunny Israel

(2011) W. Saliba et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue

(2010) S. Knippenberg et al.   ACTA NEUROLOGICA SCANDINAVICA

Effects of Parathyroid Hormone on Immune Function

(2010) Abdallah Sassine Geara et al.   Clinical & Developmental Immunology

Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women

(2010) Kerrie M. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vitamin D Suppresses Th17 Cytokine Production by Inducing C/EBP Homologous Protein (CHOP) Expression

(2010) Seon Hee Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulatory Effects of Interferon-β on Osteopontin and Interleukin-17 Expression in Multiple Sclerosis

(2010) Jian Hong et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis

(2010) Joost Smolders et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

(2010) J. M. Burton et al.   NEUROLOGY

Immunomodulatory effects of Vitamin D in multiple sclerosis

(2009) J. Correale et al.   BRAIN

Vitamin D and chronic pain

(2008) Sebastian Straube et al.   PAIN

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

(2007) John S. Tzartos et al.   AMERICAN JOURNAL OF PATHOLOGY

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

(2007) M Soilu-Hanninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY